Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Versatis vs pregabalin for postherpetic neuralgia

    • 14 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Versatis vs pregabalin for postherpetic neuralgia. Pharmacoecon. Outcomes News 595, 6 (2010). https://doi.org/10.2165/00151234-201005950-00017

    Download citation

    Keywords

    • Lidocaine
    • Cost Effectiveness
    • Markov Model
    • Time Horizon
    • Tricyclic